CLINICAL (WHO) AND SERUM TUMOR-MARKER (CA125) RESPONSE TO PLATINUM-BASED CHEMOTHERAPY AFTER TREATMENT WITH PACLITAXEL IN PATIENTS WITH OVARIAN-CANCER (OVCA)

Authors
VERMORKEN JB HUIJSKES RVHP HOEKMAN K BURGER CW VERHEIJEN RHM HEITBRINK MA PINEDO HM
Citation
Jb. Vermorken et al., CLINICAL (WHO) AND SERUM TUMOR-MARKER (CA125) RESPONSE TO PLATINUM-BASED CHEMOTHERAPY AFTER TREATMENT WITH PACLITAXEL IN PATIENTS WITH OVARIAN-CANCER (OVCA), European journal of cancer, 31A, 1995, pp. 517-517
Citations number
1
Categorie Soggetti
Oncology
Journal title
European journal of cancer → ACNP
ISSN journal
09598049
Volume
31A
Year of publication
1995
Supplement
5
Pages
517 - 517
Database
ISI
SICI code
0959-8049(1995)31A:<517:C(AST(>2.0.ZU;2-J